Back to LTRN
UBS Group AG LTRN Position History
Lantern Pharma Inc. • Healthcare
Quarters held
12
Latest value
$120K
Q3 2026
Peak value
$120K
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $107K |
| Q3 2025 | $34K |
| Q3 2025 | $3K |
| Q4 2025 | $20K |
| Q4 2025 | $6K |
| Q4 2025 | $7K |
| Q1 2026 | $9K |
| Q1 2026 | $5K |
| Q2 2026 | $27K |
| Q2 2026 | $42K |
| Q3 2026 | $7K |
| Q3 2026 | $120K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $120K | 118.9K | — | — |
| Q3 2026 | $7K | 6.5K | — | — |
| Q2 2026 | $42K | 10.1K | — | — |
| Q2 2026 | $27K | 6.5K | — | — |
| Q1 2026 | $5K | 3.6K | — | — |
| Q1 2026 | $9K | 6.5K | — | — |
| Q4 2025 | $7K | 2.3K | — | — |
| Q4 2025 | $6K | 1.8K | — | — |
| Q4 2025 | $20K | 6.5K | — | — |
| Q3 2025 | $3K | 749 | — | — |
| Q3 2025 | $34K | 7.9K | — | — |
| Q3 2025 | $107K | 24.5K | — | — |